Centers for Disease Control and Prevention (CDC) has withdrawn the PCR process as a valid test for detecting and identifying SARS-CoV-2.

β€œAfter December 31, 2021, CDC will withdraw the request to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of the CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel, the assay first introduced in February 2020 for detection of SARS-CoV-2 only.”The CDC admits that the PCR test cannot differentiate between SARS-CoV-2 and influenza viruses.